254
|
Natural killer cell lymphoblastic leukemia/lymphoma
|
Non-Hodgkin lymphoma (NHL)
|
"" Parent
|
| | | | |
253
|
Burkitt's lymphoma (BL) [High miR-17 expression Level]
|
Non-Hodgkin lymphoma (NHL)
|
"" Parent
|
| | | | |
252
|
Burkitt's lymphoma (BL) [MYC chromosomal translocation positive]
|
Non-Hodgkin lymphoma (NHL)
|
"" Parent
|
| | | | |
251
|
Burkitt's lymphoma (BL) [EBV‐positive]
|
Non-Hodgkin lymphoma (NHL)
|
"" Parent
|
| | | | |
250
|
Burkitt's lymphoma (BL)
|
Non-Hodgkin lymphoma (NHL)
|
"" Parent
|
| | | | |
249
|
T-cell lymphoblastic lymphoma (T-LBL)
|
Non-Hodgkin lymphoma (NHL)
|
"" Parent
|
| | | | |
248
|
Burkitt's lymphoma (BL) [MYC translocation-negative]
|
Non-Hodgkin lymphoma (NHL)
|
"" Parent
|
| | | | |
247
|
"" Parent
|
Non-Hodgkin lymphoma (NHL)
|
"" Parent
|
| | | | |
246
|
P53-dependent miR induction
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
245
|
Etoposide Resistance
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
244
|
MYCN Single Copy
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
243
|
Silencing hTERT
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
242
|
Oxidative stress
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
240
|
Normal MYCN
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
241
|
Oxygen and Glucose-deprived reoxygenation (OGD/R)
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
239
|
Negative ALK expression
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
238
|
MYCN Overexpression
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
236
|
p53-mutant
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
237
|
Silencing MYCN
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |
235
|
SLC 34A2 overexpression
|
Neuroblastoma (NB)
|
"" Parent
|
| | | | |